HUNDMEJEAN MARTINA 4

What Happened Martina Hundmejean, a director of Colgate‑Palmolive Co. (CL), received annual director compensation on May 11, 2026 consisting of 2,075 stock units (reported as 2,075 shares acquired at $0) and a separate option award for 2,424 shares (reported as a derivative grant at $0). Both grants are described as annual awards under the company’s incentive compensation plan; no cash was paid in connection with these grants.

Key Details

• Transaction date: 2026-05-11; Form 4 filed 2026-05-13 (appears timely, within the usual two‑business‑day reporting window).
• Stock units: 2,075 shares credited to a stock unit account (Footnote F1).
• Option grant: 2,424-share option award (derivative) (Footnote F2); reported transaction price $0.
• Vesting for the option: becomes exercisable in equal annual installments over three years, beginning on the first anniversary of the grant (i.e., May 11, 2027) (Footnote F3).
• Shares owned after the transaction: not specified in the filing.

Context These are regular director equity awards (stock units and an option grant) under Colgate’s incentive plan and represent compensation rather than an open‑market purchase or sale. The option grant is not an exercise—vesting and exercise (and any future sales) would occur later per the vesting schedule.